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Abstract
The HIV-1 envelope glycoprotein (Env) spike is challenging to study at the molecular level, due in part to its genetic
variability, structural heterogeneity and lability. However, the extent of lability in Env function, particularly for primary
isolates across clades, has not been explored. Here, we probe stability of function for variant Envs of a range of isolates from
chronic and acute infection, and from clades A, B and C, all on a constant virus backbone. Stability is elucidated in terms of
the sensitivity of isolate infectivity to destabilizing conditions. A heat-gradient assay was used to determine T90 values, the
temperature at which HIV-1 infectivity is decreased by 90% in 1 h, which ranged between ,40 to 49uC (n=34). For select
Envs (n=10), the half-lives of infectivity decay at 37uC were also determined and these correlated significantly with the T90
(p=0.029), though two ‘outliers’ were identified. Specificity in functional Env stability was also evident. For example, Env
variant HIV-1ADA was found to be labile to heat, 37uC decay, and guanidinium hydrochloride but not to urea or extremes of
pH, when compared to its thermostable counterpart, HIV-1JR-CSF. Blue native PAGE analyses revealed that Env-dependent
viral inactivation preceded complete dissociation of Env trimers. The viral membrane and membrane-proximal external
region (MPER) of gp41 were also shown to be important for maintaining trimer stability at physiological temperature.
Overall, our results indicate that primary HIV-1 Envs can have diverse sensitivities to functional inactivation in vitro, including
at physiological temperature, and suggest that parameters of functional Env stability may be helpful in the study and
optimization of native Env mimetics and vaccines.
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Introduction
Envelope glycoprotein (Env) spikes on HIV-1 are the molecular
mediators of viral entry and the sole targets on the virus of entry
inhibitors and neutralizing antibody. Env is challenging for
molecular studies and intervention strategies, as it is associated
with high genetic diversity and significant molecular heterogeneity.
Eliciting HIV-1 neutralizing antibody to primary isolates through
vaccination has been particularly problematic [1,2,3,4]. Neutral-
ization of HIV-1 fails to correlate with antibody affinity to
described soluble Env mimetics, but has been related to antibody
recognition of native Env spikes, i.e. mature, membrane-associated
trimers of gp120-gp41 heterodimers [4,5,6,7,8]. Still, uncertainties
remain about which Env structures are functional and which are
not [8,9,10], making it difficult to establish clear structure-function
relationships. Such information is however crucial for the rational
development of native Env-based mimetics, vaccines and entry
inhibitor drugs.
Biosynthesis of HIV-1 Env begins with gp160 precursors, which
oligomerize and become processed by a convertase (e.g. furin) and
the glycosylation machinery of the host [11,12]. Mature trimers of
gp120-gp41 heterodimers then incorporate onto the membrane of
infected cells and budding virions [13]. Virion-associated Env
trimers engage host cell CD4 receptors [14,15], and coreceptors
(i.e. CCR5 or CXCR4) [16]. From the receptor contact sites on
gp120, conformational changes propagate in Env to the fusion
peptide of gp41, which inserts into the host cell membrane [17].
The process of viral entry is initiated when gp41 collapses into a
‘six-helix bundle’, which promotes fusion of the opposing virus and
host cell membranes [17].
The HIV-1 fusion process, outlined above, arguably demands
that Env trimers be labile. Indeed, a tendency for Env to dissociate
is evidenced by several observations. Ionic detergent disassembles
mature Env into gp120 monomers and various oligomeric forms of
gp41, although under milder detergent conditions, Blue Native
(BN) PAGE can be used to visualize a trimeric species of Env [9].
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(TCLA) strains of HIV-1, which can be accelerated in the presence
of soluble CD4 [18,19,20,21]. CD4 has also been revealed to
cause rapid inactivation of HIV-1 Env on cell-free virions [22].
Finally, heat treatment of HIV-1 at 56uC has been shown to
promote gp120 shedding [10,23].
Co-displayed with native HIV-1 Env on virions and infected
cells are non-native, but highly immunogenic species of Env that
display non-neutralizing gp120 and gp41 epitopes [8,9,24,25].
Such species may include unprocessed gp160, misfolded Env
oligomers with possible mixed disulfides or aberrant glycosylation,
gp41 stumps from which gp120 has been shed, and possibly
gp120-gp41 heterodimers [8,9,26,27,28,29]. Adding to this
complexity, HIV-1 exists as a diverse quasispecies in infected
individuals, and multiple viruses can infect the same cell producing
progeny virions that display Envs from different parents. Although
non-neutralizing monoclonal antibodies (mAbs) seem unable to
efficiently recognize functional Env trimers, these mAbs do
typically bind to various non-functional Env molecules [8,10].
Human mAbs have been described that can neutralize diverse
primary isolates of HIV-1 (e.g. b12, VRC01, 2G12 and PG9/16 to
gp120 as well as 2F5 and 4E10 to gp41), and these are important
tools with which to probe Env mimetics intended for HIV-1
vaccine development [4,10,30,31,32,33,34,35]. Neutralizing ac-
tivity by these mAbs has been attributed to their affinity for
functional Env trimers, though each cross-reacts with non-
trimeric, immature or otherwise non-functional Env molecules
[4,8,9,32].
Recent cryo-electron microscopy models of the HIV-1 Env
spike show three apical lobes corresponding to gp120 associated
(non-covalently) with three gp41 molecules anchored in the
membrane, in some cases leaving a solvent accessible hole about
the trimer axis [36,37,38,39]. At the base of the spike abutting the
viral membrane is the membrane-proximal external region
(MPER) of gp41 that has been suggested to be in a trimer stalk
configuration [36,38,40] or to have a tripod structure [37,41].
Trimer models based on the core structure of gp120 show surfaces
that are either exposed to solvent, buried within trimer interfaces,
or occluded by glycans [42,43]. Mutagenesis in Env has been used
to suggest that gp41 interacts with elements of the N- and C-
terminal domains of gp120 [42,44,45,46,47]. In particular, the
central ectodomain region of gp41 most likely interacts with C5 of
gp120, as shown by engineering of a productive intermolecular
disulfide link between gp41 and gp120, termed ‘‘SOS’’ [44,46,
48,49,50].
Stability of proteins and their complexes is often determined
using denaturation (unfolding) experiments, typically involving
heat or treatment with chaotropic denaturants. Here, whole HIV-
1 virions bearing different Envs on a common backbone were
exposed to a heat gradient infectivity assay that is analogous in
format to a typical neutralization assay, and the virions examined
for infectivity and Env stability. In certain cases, HIV-1 was also
subjected to denaturants and to prolonged incubation at 37uC. A
considerable distribution from relatively thermostable to quite
thermolabile Envs was revealed among (acute) primary isolates of
clades A, B and C. We further showed that HIV-1 virions typically
inactivated prior to complete trimer dissociation, that most highly
thermolabile Envs were also functionally unstable even at
physiological (37uC) temperature, as well as that an intact viral
membrane and MPER of gp41 help maintain spike stability. A
molecular understanding of the stability of functional Env is
central to an understanding of its evolutionary fitness, and may
also aid in the study and development of native Env mimetics and
vaccines that are stable to specific conditions in vitro and in vivo.
Materials and Methods
Plasmids and antibodies
Env-deficient, molecularly cloned backbones of HIV-1, used for
pseudotyped virus (PSV) production, including pSG3Denv [51],
pNL4-3.Luc.R-E- [52] and Q23Denv [53] were obtained through
the NIH AIDS Research and Reference Reagent Program
(ARRRP), Division of AIDS, NIAID from J. Kappes/X. Wu, N.
Landau and J. Overbaugh, respectively. The Env expression
vector pSVIIIexE7pA
2 [54], which bears rev and env under control
of the natural HIV-1 long terminal repeat (LTR), was a gift from J.
Sodroski (Harvard). The pSVIIIexE7pA
2 vector has been
modified in order to subclone different env genes as KpnI-XhoI
fragments, and these are designated pSVIII-JR-CSF, pSVIII-
ADA, pSVIII-JR-FL, pSVIII-JR2, etc. [55]. HIV-1 gp160JR2 is
identical to that of JR-FL but has three substitutions in the
membrane-proximal external region (MPER) of gp41 (i.e., S668N,
T676S, and K677N), as described previously [56]. Acute phase
HIV-1 Env panels of clades B and C were obtained from the
ARRRP (J. Mascola, D. Montefiori, B. Hahn, E. Hunter and L.
Morris) [51,57,58], and the clade A panel was a kind gift from J.
Overbaugh [59]. Env from SF162 is expressed in pCAGGS-
SF162, a gift from J. Binley (Torrey Pines Institute for Molecular
Studies), as is that of SIVmac239 that has a stop codon at position
718 which truncates the cytoplasmic tail [60]. pVSV-G [61] was a
gift from T. Friedmann (UCSD).
Antibodies used in this study were obtained from the following
sources (epitope specificities in parentheses): IgGs 2G12 (gp120
high-mannose glycans) [31], 4E10 and 2F5 (MPER) [62] were gifts
from H. Katinger (Polymun); IgGs b12 (CD4 binding site; CD4bs)
[30], b6 (CD4bs) [8], and Z13e1 (MPER) [63] were produced in
house; IgG 7B2 (gp41, principal immunodominant domain) [9]
was a gift from J. Robinson (Tulane); IgG F425 B4e8 (V3) [64] was
a gift from L. Cavacini (Harvard Medical School). Four-domain
soluble human CD4 (sCD4, contributed by Progenics Pharma-
ceuticals) was obtained from the NIH ARRRP.
Construction of pLAI-BS vector
HIV-1 molecular clone (MC) pLAI.2, contributed by K. Peden,
was obtained from the NIH ARRRP [65]. For directional
subcloning of Env (gp140) ectodomains into a common HIV-1
backbone, pLAI.2 was modified. The sequence of the modified
vector, pLAI-BS, is available upon request. Thus, an existing BglI
site in pLAI.2 (nucleotide 10702 in the bla gene) was knocked out
using Quikchange mutagenesis (Stratagene). Meanwhile, the NcoI-
XhoI fragment of pLAI.2 was subcloned into a shuttle vector, pET-
20b(+) (Novagen), and an existing BamHI site (nucleotide 8569)
was mutated from (GGATCC) to (GGATTC) using Quikchange,
and unique BamHI and SfiI/BglI sites were silently introduced into
the leader sequence (position 6372) and transmembrane domain of
env (nucleotide 6712), respectively. A second BamHI site was
similarly introduced into env (nucleotide 8055) and a 1683 bp
BamHI fragment was excised from the NcoI-XhoI stuffer fragment.
The resulting NcoI-XhoI stuffer fragment was subcloned back into
pLAI-2 (now BglI- deficient, as described above) to render pLAI-
BS, a destination vector incapable of producing infectious virus
until a BamHI-BglI fragment, corresponding roughly to gp140, is
introduced. Several heterologous gp140-fragments from R5-tropic
isolates (SF162, ADA, JR-FL, JR2 and JR-CSF) were introduced
into pLAI-BS using PCR amplification and subcloning via the
unique BamHI and SfiI/BglI sites. Resulting chimeric LAI MCs
were used to generate virus stocks, as described below. All
plasmids not obtained from the ARRRP were sequence-verified
in env.
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TZM-bl cells were obtained from the NIH ARRRP, as
contributed by J. Kappes and X. Wu [51]. HEK293T cells were
obtained from the American Type Culture Collection. Both cell
lines were maintained in Dulbecco’s modified Eagle’s medium
(DMEM; Invitrogen) containing 10% heat-inactivated fetal bovine
serum, 20 mM glutamine, 100 U/ml penicillin and 100 mg/ml
streptomycin. MT-2/CCR5DCT cells are MT-2 (CXCR4
+) cells
that have been transfected and selected to stably express high
levels of cytoplasmic tail-truncated CCR5 receptors (a gift from D.
Mosier, TSRI) [66]. MT-2/CCR5DCT cells were cultured in
RPMI 1640 supplemented with 10% heat-inactivated fetal bovine
serum, 20 mM glutamine, 100 U/ml penicillin and 100 mg/ml
streptomycin (Invitrogen). Peripheral Blood Mononuclear Cells
(PBMC) were purified from a pool of at least 3 donors from the
Scripps Normal Blood Donor program using a Ficoll-Hypaque
method according to the manufacturer’s instructions (Sigma).
Mammalian cell cultures were incubated at 37uC in a humidified
5% CO2 environment.
HIV-1 PSVs were produced by co-transfection of HEK293T
cells using an Env complementation plasmid and either pNL4-3-
Luc, Q23Denv, or pSG3Denv at a 1:2 ratio. Replication competent
HIV-1 was produced by transfection using the appropriate pLAI-
Env chimeric MC. In general, cells were transfected at 70–95%
confluency using polyethanolimine (PEI; 25 kDa, Sigma-Aldrich)
diluted in serum free Opti-MEM (Invitrogen) at a DNA:PEI ratio of
1:3.5 [67]. Virus-containing supernatants were collected at 48 and/
or 72 h post-transfection, cleared of cellular debris by centrifugation
at 3,0006 g for 15 min, sterile filtered (0.2 mm) and either used
immediately, or frozen no more than once at 280uC. Virus-
containing supernatants were concentrated, as necessary, by
centrifugation at 20,0006 g for 45 min at 4uC, followed by
resuspension of the viral pellet in an appropriate volume of PBS.
HIV-1 MCs were amplified and cultured in MT-2/CCR5DCT
cells or PBMCs. Cells were infected at an m.o.i. of 0.01. Virus
containing supernatants were harvested when maximum titer was
reached, as determined using the TZM-bl cell infectivity assay,
usually 7–9 days post infection.
HIV-1 infectivity assay (TZM-bl)
HIV-1 infectivity was determined as described previously [51].
Briefly, TZM-bl cells were seeded in 96-well plates at 10
4 cells per
well in 100 ml complete DMEM and incubated for 24 h at 37uC.
Virus samples were added to cells in a total volume per well of
200 ml DMEM. Cells were harvested 48 h post-infection, and
HIV-1 LTR-induced luciferase activity in the cells was determined
using the Luciferase Assay System (Promega). Results are reported
in relative luminescence units (RLU) as measured on an Orion
microplate luminometer (Berthold Instruments).
ELISAs
(i) p24(Gag) ELISA. Microtiter wells were coated overnight
at 4uC with 50 mlo f5mg/ml sheep anti-p24 (Aalto) and blocked
using 4% non-fat dry milk (NFDM) in PBS. Virions were lysed by
adding 1% Empigen (final concentration) in PBS and 50 ml were
transferred to anti-p24-coated wells. After incubating for 2 h at
37uC, p24 was probed using alkaline phosphatase conjugated
sheep-anti-p24 (Aalto), and the assay developed using the AMPAK
amplification kit (Argene), according to the manufacturer’s
directions.
(ii) gp120 ELISA. gp120 ELISAs were performed as p24
ELISAs with the following exceptions: microtiter wells were coated
with Galanthus nivalis lectin (GNL; 5 mg/ml in PBS), and probed
using an anti-gp120 monoclonal antibody (mAb) cocktail (b12 and
B4e8; 1 mg/ml each) followed by detection using an HRP-
conjugated anti-human Fc (Jackson) secondary reagent. The
colorimetric signal was produced using the TMB substrate
(Pierce) and absorbance at 450 nm was measured using a
microplate reader (Molecular Devices).
HIV-1 reverse transcriptase activity assay
The HIV-1 reverse transcriptase activity assay was performed as
described by the manufacturer (Colorimetric Reverse Transcrip-
tase Assay, Roche).
Temperature gradient infectivity assay for HIV-1
To determine sensitivity of HIV-1 infectivity to heat treatment,
a gradient PCR block (Mastercycler Gradient, Eppendorf) was
used. MC and PSV virion samples were incubated in parallel on a
thermal gradient (12 temperatures) from 37 to 57uC for 1 h.
Temperature accuracy of the block was verified using a K element
probe (Ebro) in all wells. Virus-containing samples were loaded
onto a 96-well PCR plate (100 ml per well). Following heat
treatment, samples were allowed to cool to RT prior to
determination of HIV-1 infectivity using TZM-bl cells. Samples
that produced RLUs below 150,000 or above 1,500,000 following
a 1 h treatment at 37uC were considered outside of the linear
range of the assay and were excluded. For determination of T90,
RLU data were background-subtracted using RLU counts
generated from uninfected cells (typically ,3,000 RLU) and
normalized according to the 37uC data point. The assay is not
considered sensitive at or below 0.1% maximal infectivity, so all
values at or below this level of infectivity were designated 0.1%
infectivity for plotting purposes. This adjustment does not affect
the T90 value or any conclusions derived from the data. Replicate
data were curve fitted using either a cubic spline or log dose
response equation with similar outcomes, and the temperature
corresponding to 90% reduction of infectivity relative to treatment
at 37uC was determined using Prism version 5.0 software
(Graphpad, CA).
HIV-1 infectivity half-life (t1/2)a t3 7 uC
HIV-1 (PSV) in cleared cell culture supernatants were aliquoted
undiluted, and diluted 1:5 in DMEM, into 1.5 ml polypropylene
tubes corresponding to 4 different time points: t0,t 5h ,t 20 h,t 44 h.
Following incubation, samples were frozen at 280uC, then
synchronously thawed and HIV-1 infectivity was determined
using TZM-bl cells as described above. Replicate infectivity data
were background subtracted (average 2,000 RLU), analyzed using
a non-linear curve fit, one phase exponential decay equation
(plateau constraint=0), and the time corresponding to 50%
reduction of infectivity relative to t0 was determined using Prism
version 5.0 software (Graphpad, CA). Maximal HIV-1 infectivities
were kept within a linear dynamic range between 100,000–
1,500,000 RLU. Experiments were performed in at least triplicate
and produced a goodness of fit, r
2$0.90.
Treatment of HIV-1 with guanidinium hydrochloride
(GuHCl), urea and extreme pH
Virus samples were treated using a range of concentrations of
freshly prepared GuHCl (G9284, Sigma) or urea (U4883, Sigma)
or pH buffer (25 mM citric acid and 25 mM sodium citrate for
pH 3–6.5, and 25 mM ethanolamine HCl for pH 6.5–10).
Microcentrifuge tubes containing virus and denaturant or pH
buffer were immediately centrifuged for 45 min at 20,0006 g at
4uC to pellet the virus. The supernatant was carefully removed
and the virus pellet washed twice with sterile PBS to remove
HIV-1 Env Spike Stability Features
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in 100 ml DMEM and the virus titered using the TZM-bl
infectivity assay.
Blue Native (BN) PAGE
Virus samples were concentrated by 100-fold, treated with 1%
DDM (n-Dodecyl-ß-maltoside; Invitrogen) for 20 min on ice, then
subjected to electrophoresis on 4–16% NativePAGE Bis-Tris gels,
according to the manufacturer’s instructions (Invitrogen). Samples
were separated at RT using 120 V with dark blue cathode buffer
until the dye front migrates 1/3rd of the way down the gel. The
dark blue buffer was immediately replaced with light blue cathode
buffer and the electrophoresis resumed for the remainder the gel.
Proteins were then transferred to a PVDF membrane under wet
conditions using transfer buffer containing 10% methanol for 1 h
at 20 V on ice. Membranes were fixed for 20 min with 10% acetic
acid and 25% methanol in water. Excess Coomassie dye was
removed by incubation in methanol twice for 10 min. Membranes
were blocked in blocking buffer (4% NFDM, 0.1% Triton X-100
in PBS) for 30 min at RT and probed overnight at 4uC using
primary antibodies to gp120 (b12, 2G12 and b4e8 each at 2 mg/
ml) or to gp41 (2F5, 4E10 and Z13e1 each at 1 mg/ml) diluted in
blocking buffer. The membranes were vigorously washed four
times for 10 min each in wash buffer (0.05% Tween 20 in PBS)
and incubated for 30 min at RT with a horseradish peroxidase-
conjugated goat anti-human Fc antibody (diluted 1:3,000 in
blocking buffer). The membranes were washed as above, rinsed in
water, and HRP substrate (Super Signal West Pico Chemilumi-
nescence, Pierce) was added. Membranes were exposed to film
(Genesee Scientific) that was analyzed using a GS-800 Densitom-
eter (Bio-Rad).
SDS-PAGE
Concentrated virus samples were incubated in Laemmli Buffer
(Bio-Rad) containing 50 mM dithiothreitol (DTT) for 5 min at
100uC prior to loading on 4–15% Tris-HCl (Bio-Rad ReadyGel).
Protein samples were separated in the gel at RT using running
buffer (25 mM Tris, 192 mM Glycine, 0.1% SDS) at 120 V for
1.5 h, then transferred to PVDF membrane and processed using a
similar procedure as for BN-PAGE.
Effect of detergent-solubilization and b-cyclodextrin on
Env by BN-PAGE
Virus samples of were concentrated 100-fold, and were treated
with 1% DDM (n-Dodecyl-ß-maltoside; Invitrogen) or 70 mM 2-
hydroxypropyl-b-cyclodextrin (Sigma) prior to incubation at 4
different time points: t0,t 4h ,t 8h ,t 24 h,t 96 h. Following incubation,
samples were frozen at 280uC, then synchronously thawed and
subjected to BN-PAGE on 4–16% NativePAGE Bis-Tris gels
(Invitrogen), as described above.
In-solution virus capture assay
The capture assay was performed as previously described [10].
Briefly, microtiter wells were coated overnight at 4uC with
polyclonal anti-Fc (Jackson; 5 mg/ml in 50 ml of PBS). Wells were
blocked with 4% non-fat dry milk in PBS for 1 h at 37uC. Capture
mAbs were added to 50 ml of virus and incubated for 2 h at 37uC
in microcentrifuge tubes. Virions were pelleted at 20,0006 g for
45 min at 4uC in a microcentrifuge, resuspended in an equal
volume of PBS, and 50 ml was added to blocked microtiter wells
previously coated with the immobilized anti-Fc. Following a 1 h
incubation at 37uC, wells were washed 6 times with PBS and virus
equivalents quantified by p24 ELISA (see above).
Results
Determination of HIV-1 infectivity following heat
treatment
To determine the influence of Env stability on HIV-1 infectivity,
we began by subjecting virions that differed only in Env to heat
and then determined infectivity using TZM-bl reporter cells [51].
As the HIV-1 backbone remains constant and only Env is varied,
differences in sensitivity to heat of the chimeric virions will most
likely relate to thermostability of Env. HIV-1 pseudotyped virions
(PSVs) were produced by transfection of 293T cells using the
pSG3Denv vector and an Env-complementation vector [51]. Pilot
experiments using microcentrifuge tubes in a heat block revealed
that HIV-1JR-CSF was more stable to heat treatment than HIV-
1ADA (data not shown). To assign a quantitative parameter to this
observation in a rapid screen format, we employed a gradient
PCR block with temperatures evenly distributed from 37–57uC. A
heat inactivation curve was generated and a T90 was designated as
the temperature at which HIV-1 infectivity decreases by 90% in
1 h. Following multiple experiments, we consistently found that
HIV-1JR-CSF and HIV-1ADA had T90 values averaging around
48.8uC and 42.8uC, respectively, whether virions were normalized
for p24, Env or infectivity (Fig. 1A–E, and data not shown). We
also found that HIV-1ADA was more thermosensitive than HIV-
1JR-CSF using various fixed incubation times and temperatures, as
well as prone to more rapid decay at 37uC( Fig. 1F and 1G).
Thus, we found the thermal gradient infectivity assay to be a rapid
means of comparing thermostabilities (T90 values) of HIV-1 Env
variants on a constant backbone.
Thermostability of HIV-1 Env ectodomain variants with
different backbones
HIV-1 backbone components, such as the matrix protein (p17)
on the inner leaflet of the viral membrane that interacts with the
cytoplasmic tail of gp41 [13], could conceivably influence the T90
values in our assay. Hence, we compared T90 values of several
HIV-1 PSVs produced using either pSG3Denv, or a hetero-
subtypic HIV-1 backbone, Q23 (Clade A; [68]), with that of
replication-competent molecular clones (MCs), the latter of which
are chimeras of HIV-1LAI [65] engineered with heterologous Env
ectodomains. (Amino acid sequence identity for p17 between pLAI
and pSG3 is 89.4% and between Q23 and the clade B backbones
is 78%.) We found that reverse transcriptase (RT) thermostabilities
of four different backbones (i.e. pSG3DEnv, Q23, pLAI-2 and
pNL4-3Luc) following a 1 h incubation at various elevated
temperatures were indistinguishable (data not shown). Ninety-
percent reduction in RT activity occurred at a pre-incubation
temperature of ,52uC, which is slightly more thermostable than
the HIV-1 variant Envs tested (T90s,49uC; Fig. 1, Table 1 and
data not shown). Overall, viruses produced using the Q23
backbone were similar in thermostability to their pSG3 or pLAI
counterparts, although minor differences in T90 values (usually 1–
2uC or less) were occasionally observed (Table 1). Importantly,
LAI-Env MC chimeras were also found to have identical stabilities
as their parental Env counterparts in the PSVs (Table 1), even
though the MCs contain sequences in Env that originate from the
LAI strain, including the Env leader sequence and gp41
transmembrane and cytoplasmic tail (CT) domains. Truncation
of the gp41 CT, which eliminates Gag-Env interactions altogether
[69], had a relatively minor effect on the T90 of HIV-1JR-FL (46.1
c.f. 47.4uC; data not shown). Collectively, the above results show
that the observed differences in T90 values, when Env is varied on
a constant HIV-1 backbone, depend mainly on sequence
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MCs were used.
We also propagated chimeric HIV-1 MCs in a cell line, MT-2/
CCR5DCT, that has been engineered to stably express a
cytoplasmic tail-truncated CCR5 [66]. The T90 values of MT-
2/CCR5DCT-passaged viruses followed the same trend of most to
least stable isolates, i.e. JR-CSF§JR-FL.SF162.ADA, indicat-
ing that Env genotype again dictated the T90, whether 293T or
MT-2/CCR5DCT were used as producer cells (Table 1).
Notably, HIV-1 pseudotyped using Env from SIVmac239 or
vesicular stomatitis virus (VSV-G) were found to have relatively
low T90 values of 42uC and 43.4uC, respectively. Thus, HIV-1
variant Envs were more thermostable than that of the other two
enveloped viruses, at least on an HIV-1 backbone.
Sensitivity of HIV-1 to denaturants and pH
In assaying protein stability, the chaotropic denaturants, urea
and guanidinium hydrochloride (GuHCl), are commonly used.
Whereas heat will indiscriminately penetrate into the interior of
Env and other components of HIV-1, such as the RNA
polymerase, denaturants are expected to interact mainly with
solvent-exposed Env. We also wished to determine how pH might
affect functional Env stability. To avoid toxicity to target cells, we
treated HIV-1 with denaturants or pH buffers, and then pelleted
virions to wash away residual supernatant, prior to infecting cells.
As expected, both urea and GuHCl diminished infectivity of PSVs
in a concentration-dependent manner, relative to treatment with
PBS alone (Fig. 2A). At concentrations of urea and GuHCl that
abrogated HIV-1 infectivity, RT activity was only diminished by
50% or less (Fig. 2A), suggesting that the denaturants did not
penetrate and disrupt virion cores. Interestingly, the thermolabile
HIV-1ADA was found to be equally as sensitive to urea as the more
thermostable HIV-1JR-CSF (Fig. 2B), whereas HIV-1ADA was
more sensitive than HIV-1JR-CSF to GuHCl (Fig. 2C). Moreover,
little to no difference was observed between HIV-1ADA and HIV-
1JR-CSF in sensitivity to pH across a large pH range (pH 4–10)
(Fig. 2D). Thus, with HIV-1ADA, heat, 37uC incubation and
GuHCl treatment were hyper-destabilizing, but urea and pH were
not, indicating that some specificity exists in the effect of
destabilizing conditions with particular Envs.
Excess unprocessed gp160 in virion preparations has no
effect on HIV-1 thermostability
We previously found that excess, unprocessed gp160 can
associate with virions and wondered whether this association may
have an effect on HIV-1 sensitivity to heat [10]. Using ELISA, we
measured levels of virion-associated Env and Gag (p24) for ADA
and JR-CSF and found that each had similar levels of both proteins
(Fig. 1C and D; data not shown). However, HIV-1 PSV
preparations, produced using pcDNA and pSVIII Env-comple-
mentation vectors bearing promoters from CMV and HIV-1 long
terminal repeat (LTR), respectively, contained 4–5-fold more total
Env, as compared to Env-matched MCs (Fig. 3), consistent with
our findings in a prior study [10]. SDS-PAGE revealed that excess
Env associated with the PSVs was mostly unprocessed gp160, a
portion of which was oligomeric and sensitive to DTT treatment as
reported previously (Fig. 3A) [26]. In contrast, pLAI-chimeric MCs
showed lower Env levels overall but efficient processing of gp160
(Fig. 3A). Importantly, PSV and MC virions were found to have
indistinguishable T90 values (Table 1). We also tested and found
that pLAI-chimeric (MC) HIV-1ADA has a similar infectivity half-
life (t1/2=9.261.9 h) as the HIV-1ADA PSV (t1/2=9.060.4 h)
(Fig. 1G, data not shown). Hence, the presence or absence of
excessive uncleaved gp160 in HIV-1 preparations has no apparent
effect on functional thermostability of fusion-competent Env.
Visualization of virion-associated Env trimer dissociation
using BN-PAGE
We wished to determine whether a relationship exists between
the T90 thermostability value and the extent of heat-induced
dissociation of HIV-1-associated Env trimers. To this end, we
employed BN-PAGE analysis, which can be used to separate
oligomeric forms of HIV-1 Env that are liberated from virions
using mild detergent [9,70,71]. We calibrated our BN-PAGE
using gel mobility shift assays to verify that neutralizing mAbs but
Table 1. Sensitivity of HIV-1 infectivity to heat (T90) is linked
to Env.
Env T90 (6C) (± SEM)
1 of HIV-1 using different backbones
Pseudotyped virus
(PSV)
2 Molecular clone (MC)
3
pSG3Denv Q23Denv 293T MT-2/CCR5DCT
JR-CSF 48.860.5 47.760.6 48.260.2 48.560.5
JR-FL 47.760.5 47.460.5 46.760.5 45.760.6
SF162 44.460.4 46.760.7 44.260.5 45.361.4
ADA 42.860.3 43.660.3 42.060.2 43.761.8
LAI 44.960.4 44.760.2 44.360.2 nd
4
92UG037.8 45.660.5 47.660.4 nd nd
Q23.17 42.560.5 42.960.7 nd nd
SIVmac239 41.161.3 42.260.3 nd nd
VSV-G 43.460.2 43.060.2 nd nd
1T90, the temperature at which HIV-1 infectivity decreases by 90% in 1 h, and
the standard error of the mean (SEM) of at least three independent
experiments.
2HIV-1 PSVs, produced by transfection of 293T cells using env expression
plasmids pSVIIIexe7 (JR-CSF, JR-FL, ADA), pCAGGS (SF162, SIVmac239),
pcDNA3.1 (LAI), or pVSV-G (VSV-G) in combination with the backbone vectors
pSG3Denv (clade B) or Q23Denv (clade A).
3HIV-1 MCs are LAI-chimeras (see Materials and Methods) and fully replication
competent. Virions were produced by transfection of 293T cells, or through
passage in MT-2/CCR5DCT cells, as indicated.
4nd, not determined, or material unavailable.
doi:10.1371/journal.pone.0021339.t001
Figure 1. Sensitivity of HIV-1 to heat is Env-dependent. HIV-1 PSVs on a pSG3Denv backbone and bearing Env from strains ADA or JR-CSF,
were concentrated (206) in PBS and incubated for 1 h at 1, 2 or 5 times their original concentration at various temperatures for 1 h prior to
determination of infectivity using TZM-bl cells. (A) Absolute infectivity following heat treatment of HIV-1 PSVs at different virus input levels over a
.10-fold range (1610
5–2610
6 RLU/0.1 ml, demarcated by triangles). (B) Data from panel A normalized for input infectivity, indicating T90 value is
independent of virus input. HIV-1 PSVs used in panel A were examined for relative levels of p24 (C), and gp120 (D), using p24 or gp120 ELISA,
respectively. (E) Reproducibility of T90 determination using independent stocks of HIV-1 PSVs (JR-CSF and ADA). (F) Relative infectivities of HIV-1 PSVs
(JR-CSF and ADA) following several different pre-incubation temperatures and times, as determined using the TZM-bl assay. (G) Relative infectivity
over time at physiological temperature (37uC) of HIV-1 PSVs (JR-CSF and ADA). Half-life (t1/2) of infectivity was calculated as described in the Materials
and Methods and is indicated near the point of half-maximal infectivity for each curve.
doi:10.1371/journal.pone.0021339.g001
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trimeric Env, as has been reported previously (data not shown) [9].
We found that BN-PAGE using HIV-1 PSV preparations were
frequently difficult to interpret due to the presence of excess
uncleaved gp160, a significant proportion of which is in an
oligomeric state prior to heat treatment (Fig. 3A and B), and
which is also relatively heat resistant [10]. We focused instead on
the LAI-chimeric MCs for BN-PAGE analyses, as these typically
Figure 2. Sensitivity of HIV-1 to urea and GuHCl. (A) Treatment of HIV-1 with denaturant abrogates virion infectivity under conditions in which
virion-associated RT remains active. Culture supernatants containing infectious HIV-1LAI-JR-CSF (MC) virions, passaged once in MT-2/CCR5DCT cells,
were treated using different concentrations of urea and GuHCl. Following extensive washing to remove denaturant, samples were assayed for
apparent RT activity (closed symbols) as well as for infectivity on TZM-bl cells (open symbols). Data plotted are normalized to untreated samples.
(B and C) HIV-1 (PSVs) produced in 293T cells using backbone plasmid pSG3Denv, and Env plasmids pSVIII-JR-CSF (solid line) and pSVIII-ADA (dotted
line) were incubated with indicated concentrations of (B) urea, or (C) GuHCl. Prior to infectivity determination using TZM-bl cells, virions were
pelleted and washed with PBS to remove residual denaturant. Results are an average of duplicate samples, and representative of at least two
independent experiments. (D) Sensitivity of HIV-1 to pH. HIV-1 PSVs, prepared and treated as in Fig. 3, except that citric acid (pH 2–6.5) or
ethanolamine (pH 7–10) buffers were used. Results are an average of duplicate samples, and representative of three independent experiments.
doi:10.1371/journal.pone.0021339.g002
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these virions were heated and separated by BN-PAGE, trimer
dissociation could be visualized on blots stained using mAb
cocktails against either gp120 or gp41. Notably, bands corre-
sponding to mature Env trimers (JR-FL, JR-CSF and ADA) were
found to disappear gradually at temperatures somewhat above the
T90 (Fig. 4). Moreover, the rank order of trimer thermostability
observed using BN-PAGE matched that of the T90 values (i.e. JR-
CSF.JR-FL/JR2.ADA). The results indicate that the HIV-1
isolates inactivate in a manner dependent on Env stability and that
complete dissociation of all Env spikes is not required. With HIV-
1JR-FL in particular, a band corresponding to monomeric gp120 is
shown to accumulate over the same temperature transition in
which the trimer band decays (Fig. 4). Monomeric gp120 also
accumulated as a result of heating HIV-1JR-CSF and HIV-1ADA,
but these strains also exhibited more Env heterogeneity and
spontaneously shed gp120, presumably in part as a result of BN-
PAGE sample preparation, making the accumulation of mono-
meric gp120 more difficult to monitor with these two isolates.
BN-PAGE analysis further revealed that untreated HIV-1JR-FL
displays mainly trimeric Env, whereas HIV-1JR-CSF and HIV-
1ADA produce bands corresponding to monomeric gp120 and a
form of Env that migrates at a mol. wt. of ,200 kDa (Fig. 4). The
latter band stains with both anti-gp120 and anti-gp41 mAbs
(Fig. 4), and its gel mobility shifts using non-neutralizing antibody
(e.g. IgG b6 [8,9], data not shown), so this band could be uncleaved
gp160, or processed gp120-gp41 monomers or dimers, as
previously described [9,10,28,72]. These observed differences in
heterogeneity between HIV-1 Envs were reproducible using fresh
preparations of virus. Surprisingly, thermostability (T90) of native
Env trimers did not necessarily predict the level of heterogeneity of
virion-associated trimers, as both stable and labile Envs were
found to be relatively heterogeneous (i.e. JR-CSF and ADA,
respectively) whereas HIV-1JR-FL is of intermediate thermostability
but produces relatively homogeneous trimers.
Similar to its close homolog MC HIV-1JR-FL [63], HIV-1JR2
was found to produce relatively homogeneous trimeric Env by
BN-PAGE analyses (data not shown), and was examined for Env
trimer dissociation, this time at physiological temperature (37uC).
Incubation of HIV-1JR2 at 37uC resulted in modest trimer
dissociation that accumulated over several days. Trimer dissoci-
ation was incomplete at day 4 (96 h), even though at this point
infectivity had decayed to ,1% the original level (Fig. 5A; data
not shown). When the same sample of HIV-1JR2 was subjected to
the heat gradient, extensive Env trimer dissociation was observed
at a temperature just above the T90 (Fig. 5B), similar to that
observed with the other Env trimers (Fig. 4).
In order to determine whether the viral membrane - or
components thereof - help maintain trimer stability, HIV-1 virions
were incubated in the presence or absence of the cholesterol
scavenger (2-hydroxypropyl-)b-cyclodextrin [73] or with the mild
BN-PAGE detergent, DDM, in a 37uC time-course and Env was
monitored using BN-PAGE over 96 h (Fig. 6). In the absence of
any treatment, virion-associated Env trimers from HIV-1JR-FL
only partially dissociated during the time course, as we observed
previously with HIV-1JR2. In repeated experiments, the presence
of b-cyclodextrin at HIV-inactivating concentrations slightly
increased the dissociation rate of Env trimers. In the presence of
1% DDM, Env trimers almost completely dissociated by 4 hrs,
which is faster than infectivity decays with the corresponding HIV-
1JR-FL (t1/2,16 h; data not shown). These data suggest that the
presence of the viral membrane helps stabilize native Env trimers
at 37uC as viral infectivity decays in an Env-dependent manner,
and that cholesterol contributes, albeit modestly, to this effect.
One possible explanation for Env-dependent viral inactivation
in absence of complete Env trimer dissociation at 37uC is that the
trimer spontaneously assumes a fusion-active state. HIV-1 entry
inhibitors C34 and BMS-378806 can block conformational
changes in Env required for fusion [22]. Virions that were pulse-
treated for 20 h with varying concentrations of each inhibitor at
37uC showed similar rates of viral infectivity decay as untreated
virions (data not shown), suggesting that Env trimers inactivate in a
manner distinct from that which leads to fusion.
To verify that heat-induced dissociation of virion-associated Env
trimers observed using BN-PAGE was not a phenomenon that
occurred following sample preparation, we used a previously
described in-solution virion capture assay to determine efficiency
of capture of free virions by anti-Env antibodies prior to, and
immediately following heat treatment [10]. We also used HIV-1JR-
FL produced using the pLAI backbone vector, which displays well
Figure 3. Presence of an excess of unprocessed gp160 in PSV but not MC HIV-1 virion preparations. (A) SDS-PAGE of HIV-1LAI-JR-CSF PSVs
(pcDNA) showing excess of uncleaved gp160, and HIV-1LAI-JR-CSF MC (pLAI; sequence matched in Env) showing only the much fainter gp120 band, as
well as gp41. Virus loaded was normalized by p24 ELISA. (B) BN-PAGE of samples in panel A, showing mostly oligomeric Env (PSVs and MCs), with
HIV-1LAI-JR-CSF PSVs showing greater heterogeneity in staining with the gp120 mAb cocktail, and with MCs showing much less abundant, but mainly
trimeric Env. Input virus was normalized as in A.
doi:10.1371/journal.pone.0021339.g003
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less efficiently using non-neutralizing antibody when compared to
backbone-matched HIV-1JR-CSF and HIV-1ADA [10]. Indeed, we
found that following heat treatment MC HIV-1JR-FL was now
captured less efficiently using gp120 antibodies (e.g. b12 and
2G12) but more efficiently by gp41 antibodies (e.g. 7B2 and 4E10),
consistent with the notion that native Env trimers had dissociated
from free virions, leaving behind fewer gp120 molecules associated
with the virus while revealing more gp41 epitopes in the process
(Fig. 7).
Env thermostability among acute primary isolates within
clades A, B and C
HIV-1 Envs ADA, JR-FL and JR-CSF were cloned roughly two
decades ago from a monocytotropic virus [74,75], and from the
frontal lobe and cerebrospinal fluid of a patient with severe AIDS
encephalopathy [76], respectively. To obtain thermostability data
using a broader, more recent and representative sampling of HIV-
1, Envs were sourced from three HIV-1 acute phase panels of
clades A [59], B and C [57], and T90 values were determined
(Table 2). Some of these acute Envs, such as Q259.d2.26 and
Q168.b23 (clade A), pTHRO4156 (clade B), as well as ZM53M
(clade C) were relatively thermostable (T90$48uC), similar to
HIV-1JR-CSF (Fig. 8A). However, heat labile Envs (T90#43uC)
were also found, such as Q23.17 (clade A), 6535 and pRHPA4259
(clade B), as well as ZM109F and ZM233M (clade C) (Fig. 8A).
The distribution of T90 values with these Env panels (Table 2),
and those from Table 1, ranges from ,40 to 50uC, with an
overall mean of 44.2uC, and a standard deviation of 2.4uC
(Fig. 8B). We conclude that thermostability varies significantly
among functional Envs of primary HIV-1, as sourced from both
acute and chronic natural infection, as well as of different cellular
tropisms, clades, tissues and patients.
Effect of point mutations in the MPER of Env on
thermostability
The MPER forms a stalk at the base of the trimer, and abuts the
membrane, which we in turn have shown above to contribute to
trimer stability. We have described previously a panel of MPER
Ala mutants of HIV-1JR2 [56], and decided to test the
thermostability (T90s) of these mutants. Interestingly, the majority
of the MPER Ala mutants were destabilizing (Fig. 9). Without
Figure 4. Thermally induced dissociation of HIV-1 Env trimers visualized using BN-PAGE. HIV-1 LAI-chimeric MCs bearing Envs of JR-CSF
(top), JR-FL (middle) and ADA (bottom) were treated for 1 h at temperatures ranging from 37uCt o5 7 uC, and then subjected to BN-PAGE and Western
blot analysis. Blotted membranes were probed using mAb cocktails to gp120 (IgGs b12, 2G12 and B4e8) or to gp41 (IgGs 2F5, 4E10 and Z13e1).
Positions of molecular weight standards are indicated (left), as are positions of monomeric gp120 and native gp120/gp41 trimers (right). The down
arrow (Q) on each panel indicates the T90 of the cognate virus, as reported in Table 1.
doi:10.1371/journal.pone.0021339.g004
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region (Trp, Phe, Leu, Ile) was extremely destabilizing (4–5uC
decrease in T90), whereas mutation of charged residues (Glu, Lys,
Asp) had little effect. For one of the least stable mutants, W672A,we
further measured its stability at 37uC and found that infectivity of
the mutant decayed more rapidly than wildtype as well (t1/2=6.3 h
Figure 5. Time course incubation of HIV-1 Env trimers at physiological temperature (376C) visualized using BN-PAGE. (A) HIV-1LAI-JR2
MC, produced in 293T cells, was incubated for various time intervals up to 96 h at 37uC and aliquots removed for BN-PAGE and Western blot analysis,
as in Fig. 4. Down arrows indicate the time interval in which infectivity of the cognate virus decreases by $90%. The band smearing in the 72 h lane
is an experimental artifact of sample loading. (B) The same virus sample as in Panel A was subjected to indicated temperatures for 1 h and analyzed
on BN-PAGE, as in Fig. 4, except that the electrophoresis run time was shorter causing less separation between different bands.
doi:10.1371/journal.pone.0021339.g005
Figure 6. Time course dissociation of HIV-1 Env trimers in the presence of membrane altering reagents visualized using BN-PAGE.
HIV-1LAI-JR-FL MC, produced in 293T cells, was incubated for 0 h, 4 h, 8 h, 24 h, or 96 h at 37uC in the presence of no compound (left), 70 mM
b-cyclodextrin (cholesterol scavenger; center), or 1% DDM (mild detergent; right). Following incubation for the indicated time periods, samples were
analyzed by BN-PAGE and Western blot as in Fig. 4.
doi:10.1371/journal.pone.0021339.g006
HIV-1 Env Spike Stability Features
PLoS ONE | www.plosone.org 10 June 2011 | Volume 6 | Issue 6 | e21339versus 16 h). Substitutions in the MPER have been shown previously
to affect Env incorporation into virions [77]. This made BN-PAGE
analysismore difficultwithmutantW672A;however,Envtrimersof
mutantW672Aalso appeartodissociatemore rapidlythanwildtype
(data not shown). Overall, the MPER of gp41 appears to be crucial
for maintaining stability of native Env trimers of HIV-1.
HIV-1 sensitivities to CD4 and heat are distinct
CD4 specifically primes Env trimers for fusion and can promote
shedding of gp120, particularly with TCLA strains of HIV-1
[18,19,20,21]. Although Env from the TCLA strain HIV-1LAI is
sensitive to shedding of gp120 induced by soluble CD4 and to
neutralizing antibody, we noticed that this strain was more
thermostable than some primary isolates (Tables 1 and 2). Env
spike stability has previously been shown not to predict
neutralization sensitivity [78]. Thus, for the HIV-1 panel members
we plotted cognate T90 values against previously reported IC50so f
sCD4 [79]. As expected, no linear correlation or other obvious
relationship was found between Env T90 values and IC50s of sCD4
(R=0.10; Fig. 8C). We also performed the heat gradient assay
using HIV-1 Envs JR-CSF, JR-FL, and ADA in the presence of
sCD4 at concentrations close to the IC50. In this format, we
observed at most only modest changes in T90 values due to the
presence of sCD4 (DT90#1uC), indicating that sCD4 may slightly
sensitize Env to heat but that the effects of heat and sCD4 on HIV-
1 infectivity are not strongly cooperative (Table 3).
Functional decay of select Envs at physiological
temperature (37uC)
To further test the possible physiological relevance of our
thermostability measurements, HIV-1 variant Envs with extreme
thermostabilities across the three clades (i.e. 43.1$T90s$46.8uC;
n=10) were examined for infectivity decay at 37uC. Here, we
observed a range in half-lives (t1/2) from 6.4–18.2 h (Table 4),
and found that a positive correlation existed between T90 and t1/2
values for the 10 pseudotyped viruses tested (Fig. 10;r
(Pearson)=0.686, P value=0.029), with Envs of isolates Q23.17
and sc422661.8 being the two main outliers. Significantly, we were
able to identify Envs that are generally thermostable (i.e.
T90$48uC and t1/2$16 h with Envs Q259d2.26, JR-CSF and
ZM53M) as well as those that are generally thermolabile (i.e.
T90#43uC and t1/2#9 h with Envs Q769b9, ADA/pRHPA4259
and ZM109F) from clades A, B and C, respectively.
Intersubunit disulfide bond (‘‘SOS’’) enhances Env trimer
thermostability
Introduction of two cysteine substitutions (i.e. A501C and
T605C) has previously been shown to stabilize Env in a soluble,
Figure 7. Effect of heat pre-treatment on mAb-virion capture
efficiency. HIV-1LAI-JR-FL (MC) virions, produced in 293T cells, were
incubated at the indicated temperatures for 1 h and anti-gp120 mAbs
2G12 (outer face), b12 (CD4 binding site), anti-gp41 mAbs 4E10 (MPER),
and 7B2 (immunodominant loop), and the irrelevant mAb DEN3 were
used to capture the heat treated virions in an in-solution virus capture
assay. Amount of virion (p24) equivalents captured were determined
using an in-house p24 ELISA and reported relative to background levels
captured using DEN3.
doi:10.1371/journal.pone.0021339.g007
Table 2. Thermostability (T90 values) and sensitivity to
soluble (4-domain) CD4 of HIV-1 PSVs bearing Envs from
acute phase virion panels (clades A, B and C).
Virus Infectivity
1 T90 ± SEM
2 sCD4 IC50 (mg/ml)
3
Clade A
Q259.D2.26 ++ 48.061.0 nd
4
Q168.B23 ++ 48.060.8 nd
Q461.c2 +++ 45.760.1 nd
Q769.b9 + 43.160.5 nd
Q23.17 + 42.560.5 nd
Clade B
pTHRO4156 +/2 48.861.1 0.8
SC422661.8 ++ 46.860.2 11
pTRJO4551 ++ 46.560.7 .50
pWITO4160 +/2 46.560.2 14.8
TRO +/2 46.061.5 .50
pCAAN5342 +++ 44.960.1 .50
QH0692 +/2 44.760.6 2.5
pREJO4541 ++ 44.360.5 1.8
AC10.0 ++ 43.861.1 .50
PVO ++ 43.661.3 30.6
pRHPA4259 +/2 41.760.3 5.7
6535 + 40.062.0 6.2
Clade C
ZM53M ++ 49.061.0 7.3
DU172 +/2 46.160.4 1.6
DU156.12 ++ 45.560.4 46.6
CAP210 ++ 45.560.3 2.7
ZM214M ++ 44.760.8 29.7
CAP45 ++ 44.261.5 2.1
ZM135M ++ 43.960.1 5.9
ZM197M +/2 43.560.4 5.5
ZM233M +/2 42.860.1 9.0
ZM109F +++ 42.760.4 0.3
1Infectivities were determined in TZM-bl cells and the resulting relative light
units (RLUs) were categorized as follows: +/2, 80,000–149,999; +, 150,000–
349,999; ++, 350,000–999,999; +++, $1,000,000.
2T90, the temperature in uC at which HIV-1 infectivity decreases by 90% in 1 h,
and the standard error of the mean (SEM) of at least three independent
experiments.
3sCD4 IC50 data taken from ref. [79].
4nd, not determined.
doi:10.1371/journal.pone.0021339.t002
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PLoS ONE | www.plosone.org 11 June 2011 | Volume 6 | Issue 6 | e21339Figure 8. Thermostabilities (T90 values) of acute phase standard panel viruses (PSVs) of clades A, B and C, and lack of a relationship
with susceptibility to soluble CD4. (A) Bar graph indicating the various T90 values with that of the thermostable HIV-1JR-CSF, and thermolabile
HIV-1ADA indicated with dashed lines. Env panel members that are thermostable (T90$48uC), intermediate in thermostability (43uC,T90,48uC), and
thermolabile (T90#43uC) are indicated by filled, hatched and open bars, respectively. (B) Bell curve (normal distribution) in T90 values of HIV-1 Envs
used in this study, including Envs from acute phase panels of clades A, B and C (Tables 1 and 2), n=34. Mean, 44.2uC; Std. Dev., 2.4uC; Range, 40.0–
49.0uC. The curve-fit (nonlinear regression lorentzian) was made using Prism software (Graphpad, CA). (C) Lack of correlation between T90 and
reported IC50 values of soluble CD4 against HIV-1 standard Env panels (clades B and C). Soluble CD4 IC50 data are taken from Wu et al [79], excluding
resistant isolates (IC50.50 mg/ml) for which exact values are undetermined.
doi:10.1371/journal.pone.0021339.g008
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FL-SOS, infects host cells upon addition of a reducing reagent (e.g.
dithiothreitol, DTT) [80], we wished to determine whether the
SOS disulfide might also stabilize virion-associated, full-length
Env trimers. We introduced the SOS mutations into full-length
Env in the HIV-1JR-FL-LAI MC backbone, and, using BN-PAGE
analysis, examined wt and SOS Env from virion preparations
that were normalized for Env content. The SOS disulfide was
found to enhance the stability of virion-associated trimeric Env,
as the corresponding band faded at temperatures ,3uC higher
than that of the wildtype trimeric Env (Fig. 11A). However,
despite the trimer stabilizing effect of the SOS disulfide, no
increase was observed in the T90 of SOS relative to wildtype
virions (Fig. 11B).
Discussion
In the present study, we determined specific stabilities of
functional Env trimers of HIV-1, which should help in establishing
structure-function relationships and other biological implications
of Env stability. Among the methods used to assay Env stability,
we found the thermogradient infectivity (T90) assay to be the most
rapid, high in throughput, facile, and precise. Ten Envs with
extreme T90 values were also examined for Env decay at
physiological temperature (t1/2), which yielded a positive correla-
tion. However, Envs from isolates Q23.17 and sc422661.8
deviated from this correlation. Such discrepancies may result
from a tendency of certain Envs to unfold particularly rapidly
within specific temperature ranges [81]. Additionally, tempera-
ture-dependent factors in the extrinsic medium (e.g. cofactors or
enzymes) may inactivate certain Envs more rapidly than others at
physiological temperature, and still other explanations might exist.
Hence, multiple different measures of Env stability under
physiological conditions and other methods to probe the Env
oligomer (e.g. BN-PAGE and virus capture assays) are recom-
mended if the goal is to identify native Envs of broad stability or
with specific stability profiles.
We highlight several elements necessary to make determinations
of thermostability (T90) and other stability measurements of
functional Env reproducible. First, use of cloned Envs removes
uncertainty associated with undefined quasispecies. Second, HIV-
1 backbone constancy minimizes assay variability contributed by
non-Env virion components. Though we found that backbones
and RTs of both clades A and B had remarkably similar
thermostabilities, certain RTs of HIV-1 Group O reportedly have
unusually high thermostability [82]. Third, a gradient PCR block
provides accurate temperatures and the ability to multiplex.
Fourth, using only measurements in the linear part of the
infectivity curve with non-saturating amounts of virus is crucial
to mitigating error. Fifth, HIV-1 produced in a defined cell line
overcomes possible effects of different producer cells on Env
stability and heterogeneity. In our hands, 293T producer cells
Figure 9. Change in thermostability of HIV-1JR2 (DT90 values) due to Ala mutations in the MPER of gp41. T90 values were determined for
each Ala mutant and for parental HIV-1JR2 and the DT90 values were calculated (DT90=T 90 of parental2T90 of mutant).
doi:10.1371/journal.pone.0021339.g009
Table 3. Effect of the presence of soluble CD4 on the








3 in the presence of the
indicated concentrations of sCD4:
0.3 mg/ml 1.2 mg/ml
JR-CSF 1.1 20.5 20.5
JR-FL 1.2 20.1 20.8
ADA 0.17 21.0 nd
1HIV-1 (LAI chimeric MCs) produced in 293T cells.
2Concentration of 4-domain soluble CD4 (sCD4) required to decrease HIV-1
infectivity by 50%.
3DT90=(T 90 in the presence of sCD4)2(T90 in the absence of sCD4). HIV-1 was
treated with the indicated concentrations of sCD4 and immediately subjected
to a range of temperatures for 1 h. Infectivity was measured in TZM-bl cells. nd,
not determined due to insufficient infectivity at the indicated concentration of
sCD4.
doi:10.1371/journal.pone.0021339.t003
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heterogeneity may indeed arise from asynchronous virus replica-
tion, heterogeneity in the producer cells, and/or exposure of
nascent virions to cell receptors that may promote destabilization
of Env. We note that LAI-chimeric MCs JR-CSF and SF162 were
produced in PBMCs and found to have T90 values comparable to
that produced in MT-2/CCR5DCT cells (NA, MBZ, unpublished
observations). Nevertheless, producer cell, virus stock age, and
other factors may affect intrinsic stability or copy number of
fusion-competent Env spikes on the virus [83,84]. We suggest that
Env stability assays be individually validated. Our results using
widely available Envs and Env standard panels [57] should help in
this regard.
BN-PAGE analyses lent further evidence of stability differences
in Env trimers for ADA, JR-FL and JR-CSF. Env trimer bands
tended to disappear on BN-PAGE Western blot at pre-incubation
temperatures a few degrees above the cognate T90. The lag in
temperature might be due, at least in part, to the presence of other
heat labile HIV-1 components required for infectivity (see below).
However, our present study suggests that Env is often limiting in
HIV-1 inactivation. We have previously shown that oligomers of
uncleaved gp160 can be resistant to heat induced dissociation [10],
so unprocessed Env, non-functional but relatively stable Env
trimers, or other heterogeneity in processed Env may confound
analyses of functional Env trimers on BN-PAGE. A further
possibility is that heat may alter the conformation of Env trimers
subtly, rendering them inactive but difficult to distinguish using
standard BN-PAGE. This explanation may also relate to the
persistence of Env trimers on BN-PAGE after incubation at 37uC
for four days, even though infectivity was nearly abrogated under
these conditions. Of note with BN-PAGE and capture assays, we
generally avoided PSVs and focused on intact MCs as we have
found that these are less contaminated with uncleaved Env [10].
Using both assays we have shown that heat exposes gp41 (BN-
Figure 10. Relationship between thermostability (T90) and infectivity half-life at 376C( t 1/2) for HIV-1 (PSVs) from clades A, B and C.
Pearson, r=0.686; P value (2-tailed)=0.0286 (significant). Identity of Env is shown beside each point. For emphasis, shaded regions designate areaso f
thermolabile and thermostable Envs. The arrow to the left of the origin indicates the point at which t1/2=18 min, which, at 37uC, also corresponds to
aT 90=37uC.
doi:10.1371/journal.pone.0021339.g010
Table 4. Thermostability (T90) and half-life of infectivity decay
at 37uC( t 1/2) of select HIV-1 (PSVs) from clades A, B and C.
Virus (clade) Infectivity
1 T90 ± SEM (6C)
2 t1/2 ± SEM (h)
3
Q259d2.26 (A) ++ 48.060.8 17.861.1
Q168b23 (A) ++ 48.060.8 14.261.8
Q769b9 (A) + 43.160.5 6.461.3
Q23.17 (A) + 42.560.5 15.862.4
JRCSF (B) ++ 48.860.5 18.260.7
ADA (B) ++ 42.860.5 9.060.4
sc422661.8 (B) ++ 46.860.2 7.962.1
pRHPA4259 (B) +/2 41.760.3 7.961.3
ZM53M (C) ++ 49.061.0 16.063.7
ZM109F (C) + 42.760.4 6.762.0
Mean: 45.3 Mean: 12.0
1Infectivities were determined in TZM-bl cells and the resulting relative light
units (RLUs) were categorized as follows: +/2, 100,000–149,999; +, 150,000–
349,999; ++, 350,000–999,999; +++, $1,000,000.
2T90, the temperature at which HIV-1 infectivity decreases by 90% in 1 h, and
the standard error of the mean (SEM) of at least three independent
experiments.
3t1/2, the time (in hours) at which HIV-1 infectivity decreases by 50% under
physiological conditions (37uC), and the standard error of the mean (SEM) of at
least three independent experiments.
doi:10.1371/journal.pone.0021339.t004
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7B2 against the immunodominant region of gp41, both results of
which are consistent with gp120 shedding.
We did not attempt to quantify all possible contributions from
different virion components to HIV-1 thermostability. We did
however measure RT thermostability and found it to be more
stable than Env trimers, consistent with experiments by others
[82,85]. Above ,50uC membranes may become unstable [86],
which might also help to explain greater dissociation of Env
trimers and loss of infectivity at elevated temperatures versus
physiological temperature. Indeed, we found that treatment of
virions with b-cyclodextrin - which blocks viral infection primarily
by removing essential cholesterol from the membrane [73] -
slightly increased the rate of trimer dissociation. Moreover,
complete solubilization of Env in mild detergent led to rapid
dissociation. Other thermolabile components may include the
Figure 11. Intersubunit disulfide bond (‘‘SOS’’) increases apparent thermostability of trimeric Env but does not increase
thermostability of infectivity (T90) of HIV-1LAI-JR-FL. (A) BN-PAGE analysis of the thermostability of wildtype HIV-1LAI-JR-FL and SOS-HIV-1LAI-JR-FL,
incubated as whole virions for 1 hr at indicated temperatures, then prepared for BN-PAGE and subsequent blotting using mAb cocktails to gp120
and gp41. (B) Thermostability comparison in the infectivity assay of wildtype HIV-1LAI-JR-FL and SOS-HIV-1LAI-JR-FL, using the same heat gradient as in
panel A.
doi:10.1371/journal.pone.0021339.g011
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native Env (tE), and that of the HIV backbone (tHB), are designated
as the two main contributors to HIV-1 infectivity decay, the
infectivity half-life of the whole particle (t1/2(HIV-1)) can be
described using the ‘harmonic mean’ of the component parts: t1/
2(HIV-1)=(t E*tHB)/(tE+tHB). Thus, for labile Envs (i.e. tE«tHB), tE has
the most weight in determining t1/2(HIV-1). Conversely, when Env
is stable (i.e. tE»tHB), t1/2(HIV-1) approaches the half-life of the
backbone, tHB. Thus, heat gradient/infectivity assays may be less
sensitive to measurement of T90 and t1/2 (37uC) values beyond
,48–50uC and ,20 h, respectively, due to inactivation of the
viral backbone. Screening more virus backbones may help resolve
this issue.
HIV-1ADA was shown to be more susceptible than HIV-1JR-CSF
to GuHCl. We found that GuHCl treated and washed (pelleted)
virions showed faded Env trimer bands by BN-PAGE (unpub-
lished observations, ER, DPL, MBZ), suggesting that Env trimers
were forced to dissociate. However, unlike heat and GuHCl, urea
and pH changes affected ADA and JR-CSF equally. The nature of
the discrepancy in activity of the two denaturants is unknown, but
might relate to a hyper-sensitivity of ADA to the presence of
charged ions with the GuHCl salt that are absent with urea, a non-
ionic chaotrope. A recent study identified a substitution in the
inner domain of gp120 (H66N) that alleviated a ‘‘cold labile’’
phenotype attributed to Env of HIV-1ADA [81]. In that study,
ADA was found to inactivate over several days at 4uC, due in part
to exposure of cryptic sites on gp41. Indeed, using BN-PAGE we
have observed gp41 dissociation product with GuHCl-treated
HIV-1 (DPL, MBZ; unpublished observations). Future experi-
ments will focus on functional Env stability under various
destabilizing conditions in combination with Env mutagenesis to
identify and understand differences in sensitivity of Env to
spontaneous and induced inactivation (DPL, MBZ; manuscript
in preparation). Overall, our data show that Env can be
irreversibly inactivated in ways that are specific, a feature
reminiscent of Env sensitivity to irreversible inactivation by
different entry inhibitors [89].
The majority of HIV-1 Envs tested from clades A, B and had
thermostabilities within ,2uC of the mean T90, 44.2uC, suggesting
a selective pressure in vivo that tightly regulates Env trimer stability.
As different parameters of protein stability often can correlate
[90,91], it is possible that thermolabile HIV-1 Env variants will
also be less fit in vivo due to more rapid infectivity decay in portals
of viral entry. Unstable Envs might be more susceptible to elevated
temperatures during fever, mechanical stresses encountered during
viral trafficking such as transcytosis or trans-display on cells like
DCs, and to destabilizing ligands including antibody [92,93]. Envs
that are generally more stable will tend to fare better in such
situations; however, undergoing fusion may become increasingly
difficult. Gp120 shedding from labile spikes has been suggested to
contribute to pathogenesis and immune dysregulation, although
the significance of these effects is controversial. Finally, stability of
Env may affect adaptive immune responses in unknown and likely
complex ways involving Env quaternary structure, Env processing,
post-translational modifications such as glycosylation, T-cell
epitope peptide processing rates, and other parameters affecting
Env immunogenicity. In our study, we observed no significant
difference in Env thermostability between viruses from acute and
chronic infection; however, it might be interesting to explore more
deeply the specific stabilities of Env during acquisition of infection
and disease progression. Structural elements contributing to the
narrow range in Env thermostability might be broadly conserved;
however, multiple variable elements may also co-adapt to preserve
Env fitness. Point mutagenesis cannot easily address non-additive
contributions from many distal regions of Env. For example, JR-
CSF and ADA Envs have 9.1% sequence divergence, including in
V1V2, V3, V4, V5, C1, and C5, which makes it difficult if not
impossible to pinpoint single residues responsible for the different
stability phenotypes. Nevertheless, mutagenesis and Env structure-
function studies, in combination with bioinformatic tools, may
help deconstruct Env trimer stability, as would determination of
Env trimer structure in high resolution.
Mutations in many different regions of Env affect retention of
gp120 on virions or cell surfaces displaying HIV-1 Env, such as
those in the inner domain of gp120 and the central ectodomain of
gp41 [50,94,95,96]. We confirmed some of these findings with a
few mutants in our thermostability experiments (our unpublished
observations; ER, MBZ). Of recent interest, Ruprecht et al have
shown that neutralizing mAbs to the MPER of gp41 can
destabilize Env trimers [93]. Our Ala scan analysis now shows
that the MPER is also a determinant of trimer stability on
unliganded spikes. While the MPER is not thought to directly
interact with gp120 in the native trimer, it likely influences
interactions between gp41 subunits and the viral membrane
[41,94,97,98]. We found that mutation of the hydrophobic
residues in the MPER had the most destabilizing effects. In
NMR/EPR studies of membrane-embedded MPER peptides
these hydrophobic residues are most deeply immersed in the
membrane [41], and in a crystal structure of a homotrimeric
MPER peptide these same residues are buried in the trimer
interface [40]. The importance of the MPER in trimer stability
may also be linked to our observation that the viral membrane
plays an important role in stabilizing native Env, and that the
MPER can interact specifically with cholesterol and other
membrane lipids [98,99]. That the MPER is crucial for Env
stability, Env incorporation into virions and membrane perturba-
tion during fusion also helps to explain its remarkable sequence
conservation [98]. For the design of Env-based vaccines, the
MPER and other trimer determining regions can be targeted to
help stabilize Env mimetics in native form without the use of
stabilizing techniques that interrupt Env function (e.g. cleavage site
knockouts or added disulfides) that alter the antigenic structure of
Env.
We found no clear relationship between Env trimer thermosta-
bility and sensitivity of HIV-1 to soluble CD4 or neutralizing
antibodies with clade B panel members (IC50s) (data not shown;
[57]). However, lack of such relationships was not unexpected.
Prior studies have found little correlation between neutralization
sensitivity with particular antibodies and sensitivity to soluble
CD4, Env copy number or retention of gp120 on HIV-1 PSVs
[78,79]. Studies have also shown that sCD4 will labilize certain
primary Envs more than others [22,100], which is explained at
least in part by the ability of structural layers in gp41 to facilitate
conformational transitions upon CD4-binding and that control the
stability between gp120 and gp41 [45,101,102]. In our study,
destabilizing effects of soluble CD4 and heat showed little synergy;
however, it may be possible to relate thermostability of CD4-
activated Env using more specific assay formats. Moreover, it is
possible that certain mutations in Env may simultaneously affect
trimer stability as well as sensitivity to neutralizing antibody
through changes to fusion efficiency or cell receptor recognition
[103,104]. Finally, certain antibodies may themselves be destabi-
lizing to Env trimers, as has been demonstrated previously using
the b12 neutralizing antibody [105] and more recently using
MPER antibodies [93].
Eliciting a particular neutralizing antibody response that is
specific for native Env will likely be difficult if it is prone to
dissociate and the byproducts are structurally distinct. Unlike
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trimers are constantly replenishing decayed ones, non-native
byproducts of Env spike decay will accumulate with vaccines
administered by bolus injection. These byproducts may divert B
cells with cross-reactive B cell receptors (BCRs) away from native
trimers, particularly when present on the same particle [8,9].
Moreover, gp120, gp41 six-helix bundles, as well as unprocessed
gp160 may be more stable than native Env and can persist in
lymph nodes for many months [106,107]. This scenario may be
exacerbated by the low copy number of native trimers that are
sparsely distributed on virions [108,109]. We found evidence of
physical dissociation of Env trimers after 4 days (96 h) at
physiological temperature. At this rate in vivo, trimer dissociation
or other forms of Env decay may or may not be enough to impact
B cell affinity maturation that develops in germinal centers over
several days [110]. However, we have shown that Env dependent
inactivation at 37uC( t 1/2) of HIV-1 can be rapid (e.g. as low as 6 h
and presumably this can go lower still). The rate of decay with
HIV-1 Env that is presented to pertinent immune cells in vivo is
poorly understood [111,112], but it is certainly possible that the
stability of native Env may influence elicitation of neutralizing
antibody. Further study of the biological consequences of HIV-1
Env spike stability is therefore warranted, as is determining
whether it can be manipulated to elicit favorable neutralizing
antibody responses through immunization.
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